e-learning
resources
Stockholm 2007
Sunday 16.09.2007
Animal and
ex vivo
models of airway inflammation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Elevated expression of TLR4 and HBD2 depict COPD patients with acute respiratory failure
E. Pace, M. Ferraro, S. Mangione, A. Giarratano, G. Bonsignore, M. Gjomarkaj (Palermo, Italy)
Source:
Annual Congress 2007 - Animal and
ex vivo
models of airway inflammation
Session:
Animal and
ex vivo
models of airway inflammation
Session type:
Thematic Poster Session
Number:
882
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Pace, M. Ferraro, S. Mangione, A. Giarratano, G. Bonsignore, M. Gjomarkaj (Palermo, Italy). Elevated expression of TLR4 and HBD2 depict COPD patients with acute respiratory failure. Eur Respir J 2007; 30: Suppl. 51, 882
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Lane-hamilton syndrome and CCF: a fatal association
Related content which might interest you:
Elevated expression of TLR4 and HBD2 but decreased levels of IP-10 in COPD with severe exacerbation
Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD
Year: 2008
Decreased toll-like receptor 4 expression in induced sputum associated with increased frequency of acute exacerbation in COPD patients
Source: Annual Congress 2009 - COPD: basic science and clinical studies
Year: 2009
Assessment of cytokine mRNA expression in patients with COPD exacerbations
Source: International Congress 2017 – Current challenges in COPD evaluation
Year: 2017
MMP-9 expression and activity is incresed in the BAL of patients with acute exacerbation of COPD
Source: Annual Congress 2012 - Inflammatory mechanisms in COPD
Year: 2012
Analysis of cytokine gene expression after treatment and pulmonary rehabilitation of acute exacerbation in COPD
Source: International Congress 2019 – Exacerbations of airway diseases
Year: 2019
Change of induced sputum TNF-a and sTNF-R55,75 levels in patients with acute exacerbations of COPD
Source: Annual Congress 2007 - Respiratory pathophysiology
Year: 2007
VEGF mRNA response to exercise in chronic heart failure and COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 76s
Year: 2001
Variation in the TLR4 gene and airway inflammation among patients with COPD
Source: Annual Congress 2009 - Genetics in the smokers corner: from inflammation in smokers via COPD to cancer
Year: 2009
TLR4 up-regulation and reduced Foxp3 expression in mechanically ventilated smokers with obstructive chronic bronchitis
Source: Annual Congress 2012 - Basic and translational studies in COPD
Year: 2012
Increased serum levels of LL37, HMGB1 and S100A9 during exacerbation in COPD patients
Source: Eur Respir J 2015; 45: 1482-1485
Year: 2015
Increased serum endotoxin levels as biomarker in acute exacerbations of COPD.
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018
Sputum VEGF level increases with treatment of COPD acute exacerbation
Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation
Year: 2012
Serum interleukin-6 levels correlate with malnutrition in patients with acute exacerbation of COPD
Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease
Year: 2009
Enhanced expression of proinflammatory cytokine (IL-18) and its receptor in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 551s
Year: 2006
Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbation
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013
Serum interferon-gamma levels in chronic obstructive pulmonary disease and asthma patients: correlation with respiratory parameters
Source: Eur Respir J 2001; 18: Suppl. 33, 75s
Year: 2001
TLR-2 and TLR-4 predicts early mortality in pediatric patients with acute hypercapnic respiratory failure treated with noninvasive positive pressure ventilation
Source: International Congress 2019 – New strategies to treat respiratory failure
Year: 2019
Upregulated expression of interleukin-33 and alternative activation of macrophages in a model of an acute exacerbation of asthma
Source: Annual Congress 2011 - Asthma: basic science and clinical studies
Year: 2011
Reduced expression of CD44 on lung macrophages from patients with COPD
Source: Annual Congress 2010 - Novel markers of lung injury
Year: 2010
Increased lung apoptosis and expression of ceramide in subjects with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2009 - COPD: basic science and clinical studies
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept